Multiple sclerosis (MS) manifests in various subtypes, with the bulk of disability occurring among individuals with progressive disease. According to Dr. Fred Lublin, the primary drivers of burden in MS are motor dysfunction and cerebellar dysfunction, and there are numerous facets that account for the growing burden of the neurological condition. Dr. Gary Owens noted that the economic burden of MS can really be categorized into 3 phases: Phase 1 is the cost burden associated with initial presentation and the ensuing, intense diagnostic evaluation period; Phase 2 is comprised of diagnosed patients receiving disease-modifying treatments; and Phase 3 consists of patients with progressive disease and the expenditures associated with chronic care.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Study Finds Obesity May Worsen Multiple Sclerosis: Genetic Analysis Points to Causal Link
November 21st 2024A new study aimed at exploring the relationship between obesity and multiple sclerosis severity using genetic data finds that higher BMI and other obesity measures were associated with increased disability progression in patients with MS.
Read More
Bridging the Vaccination Gap: Insights on Global Immunization Challenges
July 30th 2024On this episode of Managed Care Cast, we speak with Jeffery A. Goad, PharmD, MPH, 2024-2025 president of the National Foundation for Infectious Diseases, on the recent report from the World Health Organization and UNICEF on public immunization rates, with national and global health implications.
Listen